Skip to main content
Equibles

Invesco Ltd.

Position in VYGR — Voyager Therapeutics, Inc.

CIK 914208 Atlanta, GA
Back to VYGR Full portfolio

Position in VYGR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$743,221
+$283,222 QoQ
Shares Held
212,349
+78.2% QoQ
Ownership
0.345%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 135 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority Sole 0% Shared 99% None 1%

Common Shares in VYGR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Invesco Ltd. holds $14,420,023,301 across 296 Biotechnology names. VYGR ranks #167 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 8,043,052 $3,995,225,212
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,940,665 $2,457,162,245
3 ALNY
Alnylam Pharmaceuticals, Inc.
 3,754,318 $1,130,162,341
4 INCY
Incyte Corp
 4,080,461 $462,561,050
5 ARGX
Argenx SE
 443,990 $411,920,598
6 AXSM
Axsome Therapeutics, Inc.
 1,671,684 $409,178,086
7 MRNA
Moderna, Inc.
 5,780,299 $404,794,337
8 LGND
Ligand Pharmaceuticals Inc
 1,201,644 $379,827,645

All Filings in VYGR

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $743,221 212,349
2026-03-31 $459,999 119,171
2025-12-31 $455,878 116,000
2025-09-30 $422,531 90,478
2025-06-30 $196,855 63,298
2025-03-31 $164,063 48,540
2024-12-31 $137,054 24,172
2024-09-30 $131,782 22,527
2024-06-30 $1,043,826 131,963
2024-03-31 $196,030 21,056
2023-12-31 $162,081 19,204
2023-09-30 $268,204 34,607
2023-06-30 $2,302,274 201,072
2020-09-30 $639,601 59,944
2020-06-30 $755,823 59,891
2020-03-31 $769,578 84,107